Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: Involvement of isoprostanes

Journal of the American College of Cardiology

Volumn 31, Issue 7, 1998, Pages 1687-1694

  Möbert, Jacqueline ^a   Becker, Bernhard F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; INDOMETACIN; ISOPROSTANE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANAEROBIC METABOLISM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY VASCULAR RESISTANCE; ENZYME INHIBITION; GUINEA PIG; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PERFUSION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; CYCLOOXYGENASE INHIBITORS; DINOPROST; GUINEA PIGS; HEART; HEMODYNAMIC PROCESSES; HYDRAZINES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; RECEPTORS, THROMBOXANE; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0345164357     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00158-2     Document Type: Article

References (32)

1. Berger H.J., Zaret B.L., Speroff L., Cohen L.S., Wolfson S. Regional cardiac prostaglandin release during myocardial ischemia in anesthetized dogs. Circ Res. 38:1976;566-571.
2. Karmazyn M. Contribution of prostaglandins to reperfusion-induced ventricular failure in isolated rat hearts. Am J Physiol. 251:1986;H133-H140.
3. Okada T. Hypoxia-induced change in prostanoids production and coronary flow in isolated rat heart. J Mol Cell Cardiol. 23:1991;939-948.
4. Porter N.A., Caldwell S.E., Mills K.A. Mechanisms of free radical activation of unsaturated lipids. Lipids. 30:1995;277-290.
5. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
6. 2 receptors . J Clin Invest. 90:1992;136-141.
7. 2α, in rabbit lung in situ. Am J Physiol. 263:1992;H660-H663.
8. 2) in isolated guinea pig hearts. J Cardiovasc Pharmacol. 29:1997;789-794.
9. Bonow R.O., Lipson L.C., Sheehan F.H., et al. Lack of effect of aspirin on myocardial infarct size in the dog. Am J Cardiol. 47:1981;258-264.
10. Grover G.J., Schumacher W.A. Effect of the thromboxane receptor antagonist SQ 30741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve. J Pharmacol Exp Ther. 248:1989;484-491.
11. Schwartz L.M., Raschke P., Becker B., Gerlach E. Adenosine contributes to neutrophil-mediated loss of myocardial function in post-ischemic guinea-pig hearts. J Mol Cell Cardiol. 25:1993;927-938.
12. Becker B.F., Reinholz N., Ozcelik T., Leipert B., Gerlach E. Uric acid as radical scavenger and antioxidant in the heart. Pflügers Arch. 415:1989;127-135.
13. Neely J.R., Liebermeister H., Battersby E.J., Morgan H.E. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 212:1967;804-814.
14. Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057-1058.
15. Levi R., Burke J.A., Guo Z.-G., et al. Acetyl glyceryl ether phosphorylcholine (AGEPC) a putative mediator of cardiac anaphylaxis in the guinea pig . Circ Res. 54:1984;117-124.
16. Needleman P., Turk J., Jakschik B.A., Morrison A.R., Lefkowith J.B. Arachidonic acid metabolism. Annu Rev Biochem. 55:1986;69-102.
17. Prinzen F.W., Van der Vusse G.J., Arts T., Roemen T.H.M., Coumans W.A., Reneman R.S. Accumulation of nonesterified fatty acids in ischemic canine myocardium. Am J Physiol. 247:1984;H264-H272.
18. Coker S.J., Parrat J.R., Ledingham I.M.A., Zeitlin I.J. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature. 291:1981;323-324.
19. Lewy R.I., Wiener L., Walinsky P., Lefer A.M., Silver M.J., Smith J.B. Thromboxane release during pacing-induced angina pectoris possible vasoconstrictor influence on the coronary vasculature . Circulation. 61:1980;1165-1171.
20. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 2:1988;349-360.
21. Flynn P.J., Becker W.K., Vercellotti G.M., et al. Ibuprofen inhibits granulocyte responses to inflammatory mediators a proposed mechanism for reduction of experimental myocardial infarct size . Inflammation. 8:1984;33-44.
22. Jugdutt B.I., Hutchins G.M., Bulkley B.H., Pitt B., Becker L.C. Effect of indomethacin on collateral blood flow and infarct size in the conscious dog. Circulation. 59:1979;734-743.
23. Bloor C.M., White F.C., Sobel B.E. Coronary and systemic hemodynamic effects of prostaglandins in the unanesthetized dog. Cardiovasc Res. 7:1973;156-166.
24. Brezinski M.E., Yanagisawa A., Darius H., Lefer A.M. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemic in cats. Am Heart J. 110:1985;1161-1167.
25. Grover G.J., Parham C.S., Schuhmacher W.A. The cardioprotective effects of the thromboxane receptor antagonist SQ 30741 are not reversed by aspirin. Basic Res Cardiol. 86:1991;99-106.
26. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins. 44:1992;155-163.
27. 2α generation during coronary reperfusion a potential quantitative marker of oxidant stress in vivo . Circulation. 95:1997;2492-2499.
28. Berne R.M. Regulation of coronary blood flow. Physiol Rev. 44:1964;1-29.
29. Berti F., Rossoni G., Omini C., et al. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart. Eur J Pharmacol. 135:1987;375-382.
30. Scheuer J., Brachfeld N. Coronary insufficiency relations between hemodynamic, electrical, and biochemical parameters . Circ Res. 18:1966;178-189.
31. Holtz J., Förstermann U., Pohl U., Giesler M., Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs effects of cyclooxygenase inhibition . J Cardiovasc Pharmacol. 6:1984;1161-1169.
32. Friedman P.L., Brown E.J., Gunther S., et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med. 305:1981;1171-1175.